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respectively. GW274150 abolished the rise in the plasma levelsGW274150, a potent and highly selective inhibitor of iNOS,
of nitrate (indicating reduced NO production). GW274150 alsoreduces experimental renal ischemia/reperfusion injury.
reduced the renal dysfunction in wild-type mice to levels similarBackground. Generation of nitric oxide (NO) by inducible
to that observed in iNOS/ mice subjected to I/R. Renalnitric oxide synthase (iNOS) may contribute to renal ischemia/
MPO activity and MDA levels were significantly reduced inreperfusion (I/R) injury. The aim of this study was to investigate
wild-type mice administered GW274150 and iNOS/ micethe effects of GW274150, a novel, highly selective, potent and
subjected to renal I/R, indicating reduced polymorphonuclearlong-acting inhibitor of iNOS activity in rat and mouse models
leukocyte (PMN) infiltration and lipid peroxidation.of renal I/R.
Conclusions. These results suggest that (1) an enhanced for-Methods. Rats were administered GW274150 (5 mg/kg in-
mation of NO by iNOS contributes to the pathophysiology oftravenous bolus administered 30 minutes prior to I/R) and
renal I/R injury and (2) GW274150 reduces I/R injury of thesubjected to bilateral renal ischemia (45 minutes) followed by
kidney. We propose that selective inhibitors of iNOS activityreperfusion (6 hours). Serum and urinary indicators of renal
may be useful against renal dysfunction and injury associateddysfunction, tubular and reperfusion injury were measured,
with I/R of the kidney.specifically, serum urea, creatinine, aspartate aminotransferase
(AST) and N-acetyl--d-glucosaminidase (NAG) enzymuria.
In addition, renal sections were used for histologic scoring of
renal injury and for immunologic evidence of nitrotyrosine for- Nitric oxide (NO), generated by any one of the threemation and poly [adenosine diphosphate (ADP)-ribose] (PAR).
isoforms of nitric oxide synthase (NOS) plays an impor-Nitrate levels were measured in rat plasma using the Griess
tant role in renal function, both under normal and patho-assay. Mice (wild-type, administered 5 mg/kg GW274150, and
iNOS/) were subjected to bilateral renal ischemia (30 min- physiologic conditions [1, 2]. Although NO appears to
utes) followed by reperfusion (24 hours) after which renal play an important functional role within the proximal
dysfunction (serum urea, creatinine), renal myeloperoxidase tubule, it can also contribute to pathophysiology of this(MPO) activity and malondialdehyde (MDA) levels were mea-
part of the kidney [3, 4]. All three isoforms of NOSsured.
have been located in the kidney; the constitutive isoformResults. GW274150, administered prior to I/R, significantly
reduced serum urea, serum creatinine, AST, and NAG indicat- [endothelial NOS (eNOS)] and neuronal NOS (nNOS)]
ing reduction of renal dysfunction and injury caused by I/R. isoforms have been identified in the renal vasculature
GW274150 reduced histologic evidence of tubular injury and and macula densa, respectively [1, 2] and inducible NOSmarkedly reduced immunohistochemical evidence of nitrotyro-
(iNOS) can be located and induced in several renal cellsine and PAR formation, indicating reduced peroxynitrite for-
types (e.g., in glomerular mesangial and proximal tubularmation and poly (ADP-ribose) polymerase (PARP) activation,
cells) by cytokines, lipopolysaccharide (LPS), and during
renal ischemia/reperfusion (I/R) [2–6], leading to renal
Key words: rat, mouse, kidney, reperfusion injury, renal dysfunction, cell injury [7]. Recently, it has been suggested that antubular injury, nitric oxide, inducible nitric oxide synthase, poly (ADP-
imbalance between the expression and activity of iNOSribose) polymerase, peroxynitrite, myeloperoxidase, malondialdehyde,
oxidative stress. and eNOS is an important contributor to the pathophysi-
ology of acute renal failure (ARF) [8] and there is goodReceived for publication June 13, 2002
evidence that NO is implicated in renal reperfusion-and in revised form August 27, 2002
Accepted for publication October 10, 2002 injury [6, 9, 10]. Several in vivo and in vitro investigations
have demonstrated how inhibition of the expression or 2003 by the International Society of Nephrology
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activity of iNOS, or absence of iNOS itself, can amelio- activity [29, 33]. GW274150 is a sulfur-substituted aceta-
mine amino acid derivative of l-lysine which, like 1400W,rate or prevent renal I/R injury or hypoxic injury to the
proximal tubules demonstrating that NO, generated by has a very high degree of selectivity for iNOS versus both
eNOS (250-fold) and nNOS (80-fold) [29, 33]. As withiNOS, contributes to renal I/R injury [5, 6, 11–15]. Fur-
thermore, it is now clear that the production of reactive 1400W, inhibition of iNOS activity by GW274150 is nico-
tinamide adenine dinucleotide phosphate (NADPH)-oxygen species, such as hydrogen peroxide, superoxide
and hydroxyl radicals, contribute significantly to renal dependent and develops slowly, whereas inhibition of
eNOS and nNOS is rapidly reversible [29, 33] and effi-I/R injury (and associated ARF) [16, 17]. Traditionally,
reactive oxygen species have been considered to exert cacy and selectivity of GW274150 is maintained in intact
cells and tissues. Initial studies using GW274150 indicatetheir effects through a direct toxic action on target cells,
for example, reactive oxygen species cause DNA damage that unlike 1400W (and several other nonamino acid
NOS inhibitors), GW274150 does not produce acute tox-during renal I/R and oxidative stress [18] leading to the
activation of the nuclear enzyme poly (ADP-ribose) icity [29]. The half-life of GW274150 in the rat is 5 hours
and 3 hours in mice and a single injection of this iNOSpolymerase (PARP), depletion of nicotinamide adenine
dinucleotide (NAD), adenosine triphosphate (ATP), inhibitor (3 mg/kg) abolishes the increase in nitrite and
nitrate caused by an injection of endotoxin, even if endo-and ultimately cell death [19, 20]. Thus, various antioxi-
dant strategies, such as the use of tempol or desferrioxa- toxin is injected 14 hours after administration of GW274150
(abstract; Alderton W et al, Acta Physiol Scand 167:11,mine have been shown to provide beneficial actions
against renal dysfunction and injury mediated by I/R of 1999). GW274150 did not have any effect on conscious
mouse blood pressure at 100 mg/kg or on rat brain nitratethe kidney [21]. However, reactive oxygen species can
also cause indirect injury to cells. Superoxide anions at 20 mg/kg indicating high selectivity for iNOS (abstract;
Alderton W et al, Acta Physiol Scand 167:11, 1999).react with NO to form peroxynitrite [22], which causes
injury via protein tyrosine nitration [23] or via oxidant Here we investigate the effects of GW274150 on the
renal dysfunction and injury caused by I/R of the kidneyinjury subsequent to its decomposition into hydroxyl rad-
ical and nitrous oxide [23, 24]. Specifically in the kidney, of the rat and mouse in vivo. In order to ensure that
an enhanced formation of NO by iNOS does indeedperoxynitrite generation has been implicated in the patho-
physiology of renal I/R injury [6–8, 15]. contribute to renal I/R injury, we have compared the
degree of injury/dysfunction caused by I/R in either wild-Early studies have demonstrated that inhibition of all
isoforms of NOS using nonselective NOS inhibitors such type mice treated with GW274150 or in mice in which
the gene for iNOS is absent (iNOS/).as NG-monomethyl l-arginine (L-NMMA) causes a con-
comitant inhibition of eNOS activity, causing excessive
vasoconstriction and hence, exacerbates renal ischemia,
METHODS
microvascular thrombosis and mortality [25]. This is sup-
Renal I/R (rat model)ported by the finding that NG-nitro-l-arginine methyl
ester (L-NAME), a relatively selective inhibitor of eNOS This study involved 42 male Wistar rats (Tuck, Ray-
leigh, Essex, U.K.) weighing 220 to 330 g. Rats receivedactivity, augments the degree of kidney injury (glomeru-
lar thrombosis) and reduces renal perfusion in a rodent a standard diet and water ad libitum and were cared for
in accordance with both the Home Office Guidance inmodel of endotoxic shock [26]. We have recently re-
ported that l-N6-(1-iminoethyl)lysine (L-NIL) and ami- the Operation of the Animals (Scientific Procedures) Act
1986, published by Her Majesty’s Stationery Office, Lon-noethyl-isothiourea (AE-ITU) can significantly reduce
renal dysfunction and injury caused by I/R of the rat don, U.K. and the Guiding Principles in the Care and
Use of Animals published by the American Physiologicalkidney [6]. However, although both L-NIL and AE-ITU
are relatively selective inhibitors of iNOS activity [27–29], Society. Rats were subjected to bilateral renal ischemia
for 45 minutes followed by reperfusion for 6 hours asrecent studies have suggested that L-NIL may lose its
isoform selectivity at higher doses [15] and that AE-ITU described previously [20], during which time their mean
arterial blood pressures (MAP) and heart rates werecan exert nonspecific effects [30], including reduction of
the formation of reactive oxygen species by activated constantly monitored. Upon completion of surgical pro-
cedures, rats were randomly allocated into the followingpolymorphonuclear leukocytes (PMNs), inhibition of
cyclooxygenase activity and attenuation endothelin-1 four groups: (1) I/R-only group: rats were subjected to
renal ischemia for 45 minutes followed by reperfusionformation to name but a few [30–32]. All of these phar-
macologic effects may contribute to the anti-ischemic for 6 hours (N  12); (2) I/R  GW group: rats were
administered GW274150 (5 mg/kg intravenous bolus) 30effects of AE-ITU in vivo.
GW274150 ([S]-2-amino-[1-iminoethylamino]-5-thio- minutes prior to commencement of I/R (N  12); (3)
Sham  saline group: rats were subjected to identicalheptanoic acid) has recently been identified as a novel,
highly selective, potent and long-acting inhibitor of iNOS surgical procedures except for renal I/R, and were main-
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tained under anesthesia for the duration of the experi- at equivalent time points (30 minutes before sham opera-
tion and after 12 hours).ment (45 minutes  6 hours, N  12); and (4) Sham 
After performing a midline laparotomy, mice from theGW group: rats were treated identical to sham-operated
I/R groups were subjected to bilateral renal ischemia forrats except for the administration of GW274150 (5 mg/kg
30 minutes, during which the renal arteries and veinsintravenous bolus) 30 minutes prior to commencement
were occluded using microaneurysm clamps. The timeof the experimental period (45 minutes 6 hours, N 6).
of ischemia chosen was based on that found to maximizeThe time of administration and dose of GW274150
reproducibility of renal functional impairment whileused were based on those previously shown by us to
minimizing animal mortality in these animals, whichprovide beneficial actions against renal dysfunction in a
were not administered fluid intravenously [35]. After themodel of hemorrhagic shock in the rat (abstract; Izumi
renal clamps were removed, the kidneys were observedM et al, Br J Pharmacol 135:320P, 2002) and by others
for a further 5 minutes to ensure reflow, after whichto reverse delayed gastrointestinal transit in a rat model
1 mL saline at 37C was injected into the abdomen andof postoperative ileus (abstract; Alderton W et al, Acta
the incision was sutured in two layers. Mice were thenPhysiol Scand 167:11, 1999). All rats received an infusion
returned to their cages where they were allowed to re-of saline (2 mL/kg/hour) throughout the I/R period.
cover from anesthesia and observed for 24 hours. Sham-
operated mice underwent identical surgical proceduresRenal I/R injury (mouse model)
to I/R mice except that microaneurysm clamps were notIn vivo mouse studies were carried out using 36 male
applied.wild-type (C57B6) or iNOS/(129SV/C57BL/6) mice
The time of administration and dose of GW274150weighing 15 to 25 g. iNOS/mice were kindly supplied
used were based on those previously reported by us toby Professor Fons A.J. Van de Loo (Department of Rheu-
provide beneficial actions in a murine model of splanch-matology, University Hospital Nijmegen, Nijmegen, The
nic I/R [36] and by others to abolish the increase inNetherlands). In iNOS/ mice, a neocassette using
nitrite and nitrate caused by an injection of endotoxinhomologous recombination was used to replace the first
(abstract; Alderton W et al, Acta Physiol Scand 167:11,four exons of the iNOS gene as previously described
1999). Due to the shorter half-life of GW274150 in the[34]. Mice were allowed access to food and water ad
mouse (3 hours) compared to the rat (5 hours), a furtherlibitum and were cared for in compliance with Italian
dose of GW274150 (5 mg/kg intraperitoneally) was ad-regulations on protection of animals used for experimen-
ministered to mice at the mid-point of the reperfusiontal and other scientific purposes (D.M. 116192), as well
period (12 hours after renal ischemia).
as with the European Economic Community regulations
(O.J. of E.C. L358/1 12/18/1986). Measurement of biochemical parameters
Mice were anesthetized using chloral hydrate (125 At the end of the reperfusion period, 1 mL blood
mg/kg, intraperitoneally) and core body temperature main- samples were collected from rats undergoing renal I/R
tained at 37C using a homoeothermic blanket. Mice via the carotid artery into tubes containing serum gel.
were then divided into the following six groups: (1) I/R- The samples were centrifuged (6000 rpm for 3 minutes)
only group: mice were subjected to renal ischemia (30 to separate serum. All serum samples were analyzed for
minutes) followed by reperfusion for 24 hours (N  6); biochemical parameters within 24 hours after collection
(2) I/RGW group: mice were administered GW274150 (Vetlab Services, Sussex, U.K.). Serum urea and creati-
(5 mg/kg intraperitoneal bolus) 30 minutes prior to com- nine concentrations were used as indicators of renal (glo-
mencement of I/R and after 12 hours of reperfusion (N merular) function [20]. Aspartate aminotransferase (AST),
6); (3) I/R  iNOS/ group: iNOS knockout mice an enzyme located in the proximal tubule, was used as
were administered GW274150 (5 mg/kg intraperitoneal an indicator of reperfusion injury [21]. Urine samples
bolus) 30 minutes prior to commencement of I/R and were collected throughout the reperfusion period and
after 12 hours of reperfusion (N  6); (4) Sham  saline the volume of urine produced recorded. Urine flow was
group: mice were subjected to identical surgical proce- calculated based on the weight of each rat. The enzyme
dures except for renal I/R (N  6); (5) Sham  GW activity of urinary N-acetyl--d-glucosaminidase (NAG),
group: mice were treated identical sham-operated mice a specific indicator of tubular damage [21], were also mea-
except for the administration of GW274150 (5 mg/kg sured (Clinica Medica e´ Diagno´stico Dr. Joaquim Chaves,
intraperitoneal bolus) 30 minutes prior to commencing Lisbon, Portugal). Urinary NAG activity was standard-
I/R and after 12 hours of reperfusion (N  6); and (6) ized using urinary levels of creatinine to take account of
sham  iNOS/ group: iNOS knockout mice were urinary flow rate and expressed as IU/mmol creatinine.
subjected to identical surgical procedures except for re- Blood samples from anesthetized mice were obtained
nal I/R (N  6). Mice which did not receive GW274150 via cardiac puncture 24 hours after renal ischemia. Serum
levels of urea and creatinine were measured using stan-were administered 20 mL/kg saline (vehicle for GW274150)
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dard urease assay/conductivity and picric acid reactions, was measured spectrophotometrically at 650 nm. MPO
respectively. activity was defined as the quantity of enzyme required
to degrade 1 mol hydrogen peroxide at 37C and was
Histologic evaluation expressed in milliunits/100 mg wet tissue.
Renal sections were prepared as described previously
Determination of malondialdehye levelsand used for the assessment of renal I/R injury [21].
Briefly, 100 intersections were examined for each kidney Levels of malondialdehyde (MDA) in kidneys were
and a score from 0 to 3 was given for each tubular profile determined as an indicator of lipid peroxidation follow-
involving an intersection: 0, normal histology; 1, tubular ing a protocol described previously [21]. Briefly, kidney
cell swelling, brush-border loss, and nuclear condensa- tissue was weighed and homogenized in a 1.15% (w/v)
tion, with up to 1/3 of tubular profile showing nuclear KCl solution. A 100 L aliquot of homogenate was then
loss; 2, as for score 1, but greater than 1/3 and less than removed and added to a reaction mixture containing 200
2/3 of tubular profile shows nuclear loss; and 3, greater L 8.1% (w/v) lauryl sulfate, 1.5 mL 20% (v/v) acetic
than 2/3 of tubular profile shows nuclear loss. The histo- acid, 1.5 mL 0.8% (w/v) thiobarbituric acid, and 700 L
logic score for each kidney was calculated by addition distilled water. Samples were then boiled for 1 hour
of all 100 scores with a maximum score of 300. at 95C and centrifuged at 3000 g for 10 minutes. The
absorbance of the supernatant was measured spectro-Immunohistochemical localization of iNOS,
photometrically at 650 nm. MDA levels were expressednitrotyrosine and poly(ADP-ribose)
as mol/L MDA/100 mg wet tissue.
Immunohistochemical localisation of iNOS, nitrotyro-
sine (indicating the formation of peroxynitrite) and PAR Materials
[indicating activation of poly(ADP-ribose) polymerase Unless otherwise stated, all compounds used in this
(PARP)] in kidney sections was performed as previously study were purchased from Sigma-Aldrich Company,
described [5, 21]. Sections were incubated overnight at Ltd. (Poole, Dorset, U.K.). All stock solutions were pre-
4C with primary anti-iNOS, antinitrotyrosine or anti- pared using nonpyrogenic saline (0.9% [w/v] NaCl; Bax-
PAR antibody (1:500 [v/v] in phospate-buffered saline
ter Healthcare, Ltd., Thetford, Norfolk, U.K.). GW274150
(PBS) (DBA, Milan, Italy). Controls included kidney
was obtained from Alexis Biochemicals (Bingham, Not-sections incubated with buffer alone or nonspecific puri-
tingham, U.K.). LPS was obtained from Escherichia colified immunoglobulin (IgG) (DBA). After blocking en-
serotype 0.127:B8 (Sigma-Adrich Co.).dogenous avidin and biotin, specific labeling of antigen-
antibody complex was visualized using an avidin-biotin Statistical analysis
peroxidase complex immunoperoxidase technique using
All values described in the text and figures are ex-chromogen diaminobenzidine.
pressed as mean standard error of the mean (SEM) for
N observations. Each data point represents biochemicalMeasurement of nitrite/nitrate concentrations
measurements obtained from up to 12 separate animals.Concentrations of nitrite (NO2) and nitrite (NO3), the
For histologic scoring, each data point represents analy-primary oxidation products of NO subsequent to reac-
sis of kidneys taken from 6 individual animals. For immu-tion with oxygen, were measured and used as an indicator
nohistochemical analysis, the figures shown are represen-of NO synthesis. NO2/NO3 levels in rat plasma and incu-
tative of at least three experiments performed on differentbation medium from proximal tubule cells were mea-
experimental days. Statistical analysis was carried outsured as previously described [6] after enzymatic conver-
using GraphPad Prism 3.02/Instat 1.1 (GraphPad Soft-sion of NO3 to NO2 using nitrate reductase.
ware, San Diego, CA, USA). Data were analyzed using
Measurement of myeloperoxidase activity one-way analysis of variance (ANOVA) followed by
Dunnett’s post hoc test and a P value of less than 0.05Myeloperoxidase (MPO) activity in kidneys was used
was considered to be significant.as an indicator of PMN infiltration into renal tissues using
a method previously described [21]. Briefly, at the end of
the experiments, kidney tissue was weighed and homoge-
RESULTSnized in a solution containing 0.5% (w/v) hexadecyltri-
The mean  SEM for the weights of the rats used inmethylammonium bromide dissolved in 10 mmol/L po-
the in vivo part of this study was 257  6 g (N  42)tassium phosphate buffer (pH 7.4) and centrifuged for
and for mice it was 23  1 g (N  36). On comparison30 minutes at 20,000 g at 4C. An aliquot of supernatant
with sham animals, renal I/R produced significant in-was then removed and added to a reaction mixture con-
creases in serum, urinary, and histologic markers of renaltaining 1.6 mmol/L tetramethylbenzidine and 0.1 mmol/L
hydrogen peroxide. The rate of change in absorbance dysfunction and injury as described in detail below (Figs.
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1 and 2). GW274150 did not have a significant effect of
MAP or heart rate when administered to rats undergoing
sham-operation or renal I/R (data not shown).
Effect of GW274150 on renal dysfunction mediated by
I/R (rat)
Rats, which underwent renal I/R, exhibited significant
increases in the serum concentrations of urea and creati-
nine compared to sham-operated animals (Fig. 1 A and
B), suggesting a significant degree of renal (glomerular)
dysfunction. Compared to control animals (I/R only),
administration of GW274150 produced modest, but sig-
nificant, reductions in serum levels of urea and creatinine
(Fig. 1 A and B).
When compared to rats used as shams, renal I/R did
not have a significant effect on urine flow (Fig. 1C).
However, rats subjected to renal I/R, which were admin-
istered GW274150, produced a significantly greater vol-
ume of urine (Fig. 1C). Administration of GW274150 to
sham-operated rats also increased urine flow, however,
when compared to sham-operated rats administered sa-
line only, this increase was not significant (Fig. 1C).
Effect of GW274150 on renal injury caused by renal
I/R (rat)
Renal I/R produced a significant increase in urinary
NAG enzymuria (Fig. 2A), suggesting a marked increase
in tubular injury. On comparison with urinary NAG en-
zymuria in control (I/R only) rats, administration of
GW274150 produced a significant reduction of NAG
enzymuria (Fig. 2A), suggesting reduction of tubular in-
jury.
On comparison with values obtained from sham-oper-
ated animals, renal I/R produced a significant increase
in serum concentrations of AST (suggesting significant
reperfusion injury, Fig. 2B). Administration of GW274150
prior to renal I/R caused a significant reduction in serum
AST levels (Fig. 2B), suggesting a marked reduction in
reperfusion injury.
On comparison with the histologic score measured
from kidneys obtained from sham-operated animals, re-
nal I/R produced a significant increase in histologic score
(Fig. 2C). Administration of GW274150 significantly re-
Fig. 1. Effect of GW274150 on renal function in the rat. Serum ureaduced histologic score when compared to that obtained
(A), creatinine (B) levels, and (C) urine flow were measured subsequentfrom rats subjected to renal I/R only (Fig. 2C), indicating to sham operation (Sham  sal, N 12 for all determinations) or renal
a reduction in renal injury. ischemia/reperfusion (I/R only, N  12 for all determinations). Rats
were administered GW274150 (GW) (5 mg/kg intravenous bolus) 30
minutes prior to renal I/R (I/R  GW, N  12 for all determinations)Effects of GW274150 on iNOS expression and plasma
or sham operation (Sham  sal, N  6 for all determinations). DataNO levels represent mean  SEM for number of observations. *P 	 0.05 vs. I/R
only group.When compared to kidney sections obtained from
sham-operated rats, immunohistochemical analysis of
sections obtained from rats subjected to renal I/R re-
vealed positive staining for iNOS, which was unaffected
by administration of GW274150 prior to I/R (data not
shown).
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Fig. 3. Effect of GW274150 on nitric acid (NO) production during
renal ischemia/reperfusion (I/R). Plasma levels of NO2/NO3 measured
subsequent to sham operation (Sham  sal, N  12) or renal I/R (I/R
only, N  12). Rats were administered GW274150 (GW) (5 mg/kg
intravenous bolus) 30 minutes prior to renal I/R (I/R  GW, N  12)
or sham operation (ShamGW, N 6). Data represent mean SEM
for number of observations, *P 	 0.05 vs. I/R only group.
Renal I/R resulted in a significant increase in the
plasma levels of NO2/NO3 (an indicator of the formation
of NO) on comparison with values obtained from the
plasma of sham-operated animals (Fig. 3). Increased
plasma NO2/NO3 levels caused by renal I/R were signifi-
cantly reduced by administration of GW274150 to rats
prior to renal I/R (Fig. 3).
Effect of GW274150 on nitrotyrosine formation during
renal I/R
The formation of nitrotyrosine was used as an indica-
tor of nitrosative stress [6]. In comparison to renal sec-
tions obtained from sham-operated rats, which were ad-
ministered saline only (Fig. 4A), immunohistochemical
analysis of renal sections obtained from rats subjected
to renal I/R revealed positive staining for nitrotyrosine
(Fig. 4B). In contrast, substantially reduced staining was
observed in the kidney sections obtained from rats, which
were administered GW274150 (Fig. 4C). No evidence of
staining for nitrotyrosine was observed in kidney sections
obtained from sham-operated rats, which were adminis-
tered GW274150 (data not shown).Fig. 2. Effect of GW274150 on tubular and reperfusion-injury. Urinary
N-acetyl--d-glucosaminidase (NAG) activity (A) and serum levels of
aspartate aminotransferase (AST) (B) were measured subsequent to Effect of GW274150 on PAR formation during renal I/R
sham-operation (Sham sal, N  6 for NAG activity; N  12 for AST
The formation of PAR was used as an indicator oflevels) or renal ischemia/perfusion (I/R only, N  6 for NAG activity;
N  12 for AST levels). Rats were administered GW274150 (GW) the activity of the nuclear enzyme PARP as previously
(5 mg/kg intravenous bolus) 30 minutes prior to renal I/R (I/R  GW, described [19, 20] and therefore, as an indicator of reactiveN  6 for NAG activity; N  12 for AST levels) or sham operation
(shamGW, N 6 for both determinations). (C) Renal sections were oxygen species formation and oxidative stress [19, 20].
also assessed for scored for characteristic histologic signs of renal injury In comparison to renal sections obtained from sham-
(see Methods section). Each data point represents analysis of kidneys
operated rats which were administered saline only (Fig.taken from six individual animals. Data represent mean  SEM for
number of observations. *P 	 0.05 vs. I/R only group. 5A), immunohistochemical analysis of renal sections ob-
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Fig. 4. Effect of GW274150 of peroxynitrite formation during renal
ischemia/reperfusion (I/R). Immunohistochemical localization of nitro- Fig. 5. Effect of GW274150 on poly ADP-ribose polymerase (PARP)
tyrosine formation (indicative of peroxynitrite formation and nitrosative activation during renal ischemia/reperfusion (I/R). Immunohistochemi-
stress) in rat kidney sections incubated overnight with 1:500 dilution of cal localisation of poly (ADP-ribose) PAR activation (indicative of
primary antibody directed against nitrotyrosine. (A ) Sham-operated PARP activation and oxidative stress) in rat kidney sections incubated
group. (B ) I/R  saline group. In comparison, the nitrotyrosine immu- overnight with primary antibody directed against PAR (1:500 dilution).
noreactivity of kidneys from rats treated with GW274150 (5 mg/kg) (A ) Sham-operated group. (B ) I/R  saline group. In comparison, the
was markedly reduced (C ). Original magnification, 
150, figures are PAR immunoreactivity of kidneys from rats treated with GW274150
representative of at least three experiments performed on different (5 mg/kg) was markedly reduced (C ). Original magnification, 
150,
experimental days (N  12 for all groups). figures are representative of at least three experiments performed on
different experimental days (N  12 for all groups).
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gesting a significant degree of renal (glomerular) dysfunc-
tion. Compared to control rats (I/R only), administration
of GW274150 produced significant reductions in serum
levels of urea and creatinine (Fig. 6), which in the case
of serum creatinine levels, was similar to values obtained
from sham-operated mice (Fig. 6B).
When compared to control (I/R only) mice, serum
levels of urea and creatinine and, therefore, renal dys-
function, were significantly lower in iNOS-knockout mice
subjected to renal I/R (Fig. 6). Serum urea and creatinine
levels obtained from iNOS-knockout mice were not sig-
nificantly different from those obtained from wild-type
mice subjected to renal I/R (Fig. 6).
Effect of GW274150 on kidney MPO activity and
MDA levels
Compared to sham-operated animals, mice subjected
to renal I/R exhibited a substantial increase in kidney
MPO activity (Fig. 7A), suggesting increased PMN infil-
tration into renal tissues. However, administration of
GW274150 produced a significant reduction of MPO ac-
tivity on comparison with that obtained from control
(I/R only) mouse kidneys (Fig. 7A). Mice subjected to
renal I/R exhibited a substantial increase in kidney MDA
levels on comparison with sham operated mice (Fig. 7B),
suggesting increased lipid peroxidation subsequent to
the formation of reactive oxygen species. However, ad-
ministration of GW274150 produced a significant reduc-
tion in MDA levels on comparison with MDA levels ob-
tained from control (I/R only) mouse kidneys (Fig. 7B).
When compared to mice subjected to I/R only, renal
Fig. 6. Effect of GW274150 on renal function in the mouse. Serum MPO activity and MDA levels in iNOS-knockout mice
urea (A ) and creatinine (B ) levels were measured subsequent to sham subjected to renal I/R were significantly lower (Fig. 7)operation (Sham  sal, N  6 for both determinations) or renal isch-
and were not significantly different from values obtainedemia/reperfusion (I/R only, N  6 for both determinations) in the
absence or presence of GW274150 (5 mg/kg intravenous bolus adminis- from sham-operated animals (Fig. 7). The values obtained
tered 30 minutes prior to I/R and after 12 hours of reperfusion, N  for MPO activity and MDA levels in iNOS-knockout6 for both groups and determinations). Serum urea (A) and creatinine
mice subjected to renal I/R were not significantly differ-(B) levels were also measured in inducible nitric oxide synthase (iNOS)
knockout mice subjected to I/R (I/R  iNOS/, N  6 for both ent from those obtained from wild-type mice adminis-
determinations). Data represent mean  SEM for number of observa- tered GW274150 and subjected to renal I/R (Fig. 7).tions, *P 	 0.05 vs. I/R only group.
DISCUSSION
In the present study, we have shown that renal I/R oftained from rats subjected to renal I/R revealed positive
both rat and mouse kidney results in a reduction in renalstaining for PAR (Fig. 5B). In contrast, substantially
function as demonstrated by increased serum levels ofreduced staining was observed in the kidney sections
urea and creatinine. In the rat, glomerular dysfunctionobtained from rats, which were administered GW274150
correlated with the increased tubular injury suggested(Fig. 5C). No evidence of staining for PAR was observed
by increased urinary excretion of NAG and confirmedin kidney sections obtained from sham-operated rats,
using histologic analysis. Increased serum levels of ASTwhich were administered GW274150 (data not shown).
suggested reperfusion injury caused by renal I/R. The
Effect of GW274150 on renal dysfunction mediated by significant increase in NAG enzymuria observed during
I/R (mice) renal I/R correlated positively with corresponding in-
creases in AST levels (r  0.91) and with histologicMice, which underwent renal I/R, exhibited significant
scoring (r 0.89). The increase in AST levels also corre-increases in the serum concentrations of urea and creati-
nine compared to sham-operated animals (Fig. 6), sug- lated positively with histologic scoring (r  0.87). All
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that the S3 segment of the proximal tubule is particularly
susceptible to renal I/R injury [39]. Although we have
recently discovered the beneficial effects of GW274150
against renal dysfunction in hemorrhagic shock (abstract;
Izumi M et al, Br J Pharmacol 135:320P, 2002), the ability
of GW274150 to reduce renal dysfunction and injury
caused by I/R of the kidney (or to our knowledge, I/R
injury in any other organ) have not been investigated.
We demonstrate here, for the first time, that adminis-
tration of a single dose of GW274150 (5 mg/kg), prior
to I/R produces a significant reduction of renal dysfunc-
tion and injury caused by I/R of the kidney of the rat
in vivo. This conclusion is supported by the following
specific, key findings that, in a rat model of renal I/R,
GW274150 reduced the increases in (1) serum levels of
urea and creatinine, (2) urinary NAG activity, (3) serum
levels of AST, and (4) plasma levels of NO caused by
renal I/R. GW274150 also significantly reduced the histo-
logic evidence of I/R-mediated tubular injury and sub-
stantially reduced the immunohistochemical evidence of
PAR and nitrotyrosine formation. GW274150 also signifi-
cantly inhibited cytokine-stimulated NO production by
primary cultures of rat proximal tubule cells. Finally, using
an in vivo model of renal I/R in the mouse, GW274150
significantly reduced serum levels of urea and creatinine
to levels comparable to those obtained iNOS-knockout
mice subjected to I/R of the kidney. In these kidneys,
GW274150 also reduced MPO activity and MDA levels
significantly, indicating reduced PMN infiltration and
lipid peroxidation, respectively. In this study, the effects
of GW274150 were only investigated after administra-
Fig. 7. Effect of GW274150 on kidney myeloperoxidase (MPO) activ- tion prior to I/R. Thus, beneficial effects observed in thisity and kidney malondialdehyde (MDA) levels. MPO activity (A) and
study suggest that GW274150 could be given prophylac-MDA levels (B) were measured subsequent to sham operation (Sham
sal, N  6 for both determinations) or renal ischemia/reperfusion (I/R tically in circumstances where the occurrence of renal
only, N  6 for both determinations) in the absence or presence of I/R is foreseeable (e.g., during surgery for supra- or jux-GW274150 (5 mg/kg intravenous bolus administered 30 minutes prior
tarenal abdominal aortic aneurysms or renal transplanta-to I/R and after 12 hours of reperfusion, N  6 for both groups and
determinations). MPO activity (A) and MDA levels (B) were also tion or in patients subjected to cardiovascular anesthesia)
measured in inducible nitric oxide synthase (iNOS) knockout mice [40–42]. Investigations are currently underway in thissubjected to I/R (I/R  iNOS/, N  6 for both determinations).
laboratory to investigate the effects of administration ofData represent mean  SEM for number of observations, *P 	 0.05
vs. I/R only group. GW274150 during the reperfusion period.
It is interesting to consider the mechanisms by which
GW274150 provided the beneficial effects reported here.
First, GW274150 is readily transported into macrophages
these data, together with increased expression of iNOS via a broad-spectrum amino acid carrier capable of trans-
(data not shown), NO, reactive oxygen species, and per- porting both cationic and neutral amino acids (abstract;
oxynitrite formation, PARP activation, lipid peroxida- Baydoun AR et al, Br J Pharmacol 136:33P, 2002). Thus,
tion and infiltration of PMNs, confirmed a well-known it is highly likely that GW274150 will accumulate in renal
pattern of renal dysfunction and injury caused by I/R of cells, especially in proximal tubule cells, which express
the kidney and are in keeping with the notion that renal amino acid transporters and are responsible for the up-
I/R causes both glomerular and tubular dysfunction take of amino acids [43]. Second, unlike GW273629
[37, 38]. Marked tubular damage in models of renal I/R ([R]-2-amino-6-[1-iminoethylamino]-4,4 dioxo-4-thiahexa-
such as the one used here has been demonstrated pre- noic acid), which is a highly selective, but short-acting
viously [5, 6, 20, 21, 37, 38] and characteristic histologic iNOS inhibitor (abstracts; Beswick P et al, Acta Physiol
signs of marked tubular injury were observed in kidneys Scand 167:70, 1999; Alderton W et al, Acta Physiol Scand
167:11, 1999; and Knowles R et al, Acta Physiol Scandsubsequent to renal I/R, in keeping with the observation
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167:12, 1999), the half-life of GW274150 in the rat is 5 sis), and reduces perfusion in a rodent model of endo-
toxic shock [26, 53]. Thus, the beneficial hemodynamichours and 3 hours in mice and a single injection of this
iNOS inhibitor (3 mg/kg) abolishes the increase in NO2 effects of nonselective NOS inhibitors may well be due
to inhibition of iNOS activity, while the reported adverseand NO3 caused by a single injection of endotoxin, even
if the endotoxin is injected 14 hours after administration effects may be due to inhibition of eNOS activity [54, 55].
In this study, administration of GW274150 signifi-of GW274150 (abstract; Alderton W et al, Acta Physiol
Scand 167:11, 1999). There is now good evidence that cantly increased urine flow in rats subjected to I/R (Fig.
1C) by 123% (compared to rats subjected to I/R only).NO, derived from NOS, plays an important role in renal
function, both under normal and pathophysiologic condi- This was comparable to the increase in urine flow ob-
served in rats subjected to I/R which were administeredtions [1, 2] and that high levels of NO produced by iNOS
are implicated in the renal dysfunction injury associated inhibitors of NOS activity [L-NIL (115% increase) and
AE-ITU (109% increase), unpublished results] and whichwith either renal I/R [5–10, 44] or during endotoxic and
hemorrhagic shock [45, 46]. Several in vivo and in vitro also reduced renal I/R injury [6]. The mechanism in-
volved in the ability of NOS inhibitors to increase urineinvestigations have demonstrated that inhibition of iNOS
expression (e.g., using inhibitors of nuclear factor-B flow is not entirely clear. Booke et al [56] have previously
shown that inhibition of NOS activity by L-NMMAor tyrosine kinase activation), iNOS activity (e.g., using
inhibitors of iNOS activity), absence of iNOS itself (using markedly increased urine flow (and attenuated renal dys-
function) in a sheep model of endotoxic shock withoutiNOS knockout mice), or scavenging of NO (e.g., using
hemoglobin) can ameliorate or prevent NO-mediated influencing blood pressure or total renal blood flow. It
has been proposed that several factors could contributerenal injury [11–15, 44, 46], suggesting that NO, gener-
ated by iNOS, contributes to renal I/R injury. Further- to this phenomenon (e.g., an increased in renal perfusion
pressure without alteration in renal blood flow) [57].more, the generation and action of reactive oxygen spe-
cies plays an important role in pathophysiology of renal Furthermore, L-NAME has a differential effect on the
renal vasculature where it causes a greater constriction ofI/R [17–21] and the combination of superoxide and NO
leads to the formation of peroxynitrite, which also con- the efferent renal arteriole than the afferent vessel, causing
renal filtration pressure to increase [58], however, in viewtributes to renal I/R injury [6, 15, 21]. Together, along
with formation of proinflammatory cytokines [e.g., tumor of the high selectivity for GW274150 for iNOS over eNOS
[29], this is not likely to play a significant role. Further-necrosis factor-, interleukin (IL)-1, IL-6 or IL-8], the
expression on endothelium and neutrophils of adhesion more, a direct diuretic effect of GW274150 cannot be dis-
counted as an increase in urine flow was also observed inmolecules [e.g., vascular cell adhesion molecule-1 or in-
tercellular cell adhesion molecule-1 (ICAM-1)], and the sham-operated rats administered GW274150 (although
this increase did not differ significantly from urine flowoverproduction of other vasoactive mediators (e.g., eico-
sanoids via cyclooxygenase-2), formation of both reac- measured in sham-operated rats administered saline
only). Thus, the mechanism(s) underlying the ability oftive oxygen species and reactive nitrogen species contrib-
ute significantly to ischemic acute tubular necrosis and GW274150 to modulate urine flow during renal I/R cer-
tainly warrants further investigation.ARF [7, 16, 17, 47].
Pathophysiologic conditions such as renal I/R and en- GW274150 is a novel inhibitor of iNOS activity, which
has a very high degree of selectivity for iNOS versusdotoxemia cause the expression of iNOS mRNA and
protein within the kidney [7, 48] and increase eNOS both eNOS (250-fold) and nNOS (80-fold) [29, 33]
(abstract; Alderton W et al, Acta Physiol Scand 167:11,activity [49], but do not affect expression of nNOS [50].
Although endogenous NO plays an important role in 1999). In this study, GW274150 did not have any effect on
MAP (or heart rate) measured from sham-operated ratsthe control of regional blood flow and intrarenal hemo-
dynamics (e.g., in supporting medullary reperfusion) [51] or those undergoing renal I/R. Renal I/R resulted in an
increase in the plasma levels of NO, indicating increasedand supports renal blood flow after I/R [52], the contribu-
tion of NO to changes in renal function following injury is iNOS protein expression and subsequent activity. Pretreat-
ment of rats with a single bolus injection of GW274150still relatively poorly understood. Early studies suggested
that inhibition of all isoforms of NOS by nonselective abolished the increase in iNOS activity caused by I/R in
vivo without affecting the expression of iNOS protein.NOS inhibitors by, for example, L-NMMA, causes a
concomitant inhibition of eNOS activity, causing exces- One could argue that the observed beneficial effects of
GW274150 in our rat model of renal I/R are due tosive vasoconstriction and, hence, exacerbates organ isch-
emia, microvascular thrombosis and mortality [25]. This effects that are not related to inhibition of iNOS activity
(nonspecific effects). However, we also show here thatis supported by the finding that a high dose of L-NAME,
a relatively selective inhibitor of eNOS activity, reduces the renal dysfunction caused by I/R is significantly re-
duced in iNOS/ mice when compared to their wild-renal function in rats with or without endotoxemia, aug-
ments the degree of kidney injury (glomerular thrombo- type littermates, confirming the finding of previous in
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vitro and in vivo studies that absence of iNOS reduces renal tissues. This finding is in keeping with previous
renal I/R injury in rodents [11, 12]. We also report that studies reporting that depletion of PMN activity or num-
pretreatment of wild-type mice with GW274150 reduces bers reduces renal I/R injury [63, 64]. Activated PMNs
the renal dysfunction caused by I/R and, interestingly, are generally considered to be the principal effectors of
the degree of protection against renal dysfunction was renal I/R injury as they can release superoxide, which
similar in both wild-type mice treated with GW274150 can be converted to hydroxyl radicals, and NO, which can
and in iNOS/ mice. combine with superoxide to form peroxynitrite [60, 64].
In this study, renal I/R caused an increase in the immu- Hydroxyl radicals and peroxynitrite are highly reactive
nologic evidence of the generation of peroxynitrite, and cause tissue injury (e.g., via lipid peroxidation, DNA
which was identified as increased nitration of proteins.
damage, and activation of poly (ADP-ribose) polymer-Generation of peroxynitrite causes renal injury via direct
ase) [19–21, 37, 38, 64]. Furthermore, PMNs releaseoxidant injury and protein tyrosine nitration [23, 24].
MPO, which catalyses the formation of another potentNitrotyrosine formation, along with its detection using
oxidant, hypochlorous acid [60] and also generates cyto-immunohistochemical staining, was initially proposed as
kines, which, via induction of iNOS and production ofa relatively specific marker for the detection or “foot-
NO among other mechanisms, leads to further renalprint” of the endogenous formation of peroxynitrite [59],
pathophysiology [65]. Although there is still some debatealthough there is more recent evidence that certain other
as to the role of iNOS and NO in the regulation of PMNreactions can also induce tyrosine nitration (e.g., the
recruitment during inflammation [66], our study suggestsreaction of nitrite with hypochlorous acid and the reac-
tion of myeloperoxidase with hydrogen peroxide) can that inhibition of iNOS using GW274150 reduces PMN
lead to the formation of nitrotyrosine [60]. Therefore, infiltration into renal tissues and reduces renal I/R dys-
increased nitrotyrosine staining is now considered to act function. These findings are supported by the results
as an indicator of “increased nitrosative stress” rather obtained from iNOS/ mice, which demonstrated re-
than a specific marker of the generation of peroxynitrite. nal MPO levels similar to that observed in GW274150-
Respective in vivo and in vitro studies have demon- treated mice subjected to renal I/R and which displayed
strated that formation of peroxynitrite contributes to a similar magnitude of renal dysfunction subsequent to
the pathophysiology of renal I/R [6–8, 15]. Furthermore, renal I/R. These findings confirm our previous findings
peroxynitrite impairs the adhesion of the tubular mem-
that inhibition of iNOS and subsequent reduction of NObrane to the basement membrane leading to the tubular
also attenuates the expression of adhesion moleculesobstruction often observed in ARF [61]. We report here
(P-selectin and ICAM-1) with consequent reduction ofthat the selective iNOS-inhibitor GW274150 reduces
PMN infiltration and related oxidative and nitrosativestaining for nitrotyrosine residues in kidneys subjected
stress, thereby reducing splanchnic I/R [36] and supportto I/R injury. Thus, we propose that the inhibition of
the finding of Tassiopoulos et al [67] who demonstratediNOS activity afforded by GW274150 results in the atten-
that inhibition of iNOS using aminoguanidine can de-uation of the nitration of proteins, possibly secondary
crease PMN chemotaxis and sequestration and attenuateto a reduced formation of peroxynitrite.
lung injury subsequent to acute aortic occlusion.Reactive oxygen species (and peroxynitrite) produce
cellular injury and necrosis via several mechanisms, in- Renal I/R also caused a significant increase in MDA
cluding peroxidation of membrane lipids, protein dena- levels, which is a secondary product of oxidative stress
turation and DNA damage. Both produce strand breaks formed during lipid peroxidation. During I/R, the forma-
in DNA, activating the nuclear enzyme PARP, resulting tion of reactive oxygen species and the decomposition of
in the depletion of its substrate NAD. As NAD func- peroxynitrite into hydroxyl radical and nitrogen dioxide
tions as a cofactor in glycolysis and the tricarboxylic acid (both of which are potent oxidant species) lead to the
cycle, its depletion leads to a rapid fall in intracellular initiation and propagation of lipid peroxidation. Admin-
ATP a phenomenon termed “the PARP Suicide Hypoth- istration of GW274150 prior to renal I/R caused a signifi-
esis” [62]. There is recent evidence that the activation
cant reduction in MDA levels in murine kidney tissues,
of PARP may also play an important role in the injury
suggesting a significant reduction in lipid peroxidationand dysfunction caused by I/R and inflammation of the
(subsequent to a reduction in the production of NO,kidney and other organs and tissues [19, 20, 62]. We
peroxynitrite, and reactive oxygen species). The MDAdemonstrate here that inhibition of iNOS activity attenu-
levels measured in these mice were comparable to thoseates the increase in PARP activity in the kidneys of rats
measured in the renal tissues obtained from iNOS/subjected to I/R injury of the kidney.
mice subjected to I/R, confirming the role of iNOS andGW274150 significantly reduced the increase in renal
subsequent production of NO, peroxynitrite and ROSMPO activity caused by I/R of the mouse kidney, sug-
gesting a significant reduction in PMN infiltration into in the development of renal I/R injury.
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